Which has stronger earnings & valuation, MCK or HQY?

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.24 $4.76B $38.47 21.13 HealthEquity $1.31B 6.09 $215.20M $2.67 35.83

Is MCK or HQY more profitable?

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% HealthEquity 17.25% 14.75% 9.22%

Does the media favor MCK or HQY?

In the previous week, McKesson had 19 more articles in the media than HealthEquity. MarketBeat recorded 26 mentions for McKesson and 7 mentions for HealthEquity. McKesson's average media sentiment score of 1.19 beat HealthEquity's score of 0.82 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 20 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, MCK or HSIC?

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.24 $4.76B $38.47 21.13 Henry Schein $13.18B 0.74 $398M $3.31 25.92

Is MCK or HSIC more profitable?

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% Henry Schein 2.95% 15.44% 5.53%

Does the media refer more to MCK or HSIC?

In the previous week, McKesson had 18 more articles in the media than Henry Schein. MarketBeat recorded 26 mentions for McKesson and 8 mentions for Henry Schein. McKesson's average media sentiment score of 1.19 beat Henry Schein's score of 1.17 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 20 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MCK or MMSI?

In the previous week, McKesson had 24 more articles in the media than Merit Medical Systems. MarketBeat recorded 26 mentions for McKesson and 2 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.25 beat McKesson's score of 1.19 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 20 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, NEOG or MCK?

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neogen $894.66M 2.35 -$1.09B -$2.80 N/A McKesson $403.43B 0.24 $4.76B $38.47 21.13

Is NEOG or MCK more profitable?

McKesson has a net margin of 1.18% compared to Neogen's net margin of -69.93%. Neogen's return on equity of 2.35% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets Neogen -69.93% 2.35% 1.46% McKesson 1.18% -345.35% 5.85%

Does the media prefer NEOG or MCK?

In the previous week, McKesson had 24 more articles in the media than Neogen. MarketBeat recorded 26 mentions for McKesson and 2 mentions for Neogen. McKesson's average media sentiment score of 1.19 beat Neogen's score of 0.93 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 20 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMN or MCK?

In the previous week, McKesson had 9 more articles in the media than AMN Healthcare Services. MarketBeat recorded 26 mentions for McKesson and 17 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.19 beat AMN Healthcare Services' score of 0.38 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral McKesson 20 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

McKesson (MCK) Competitors

$813.01 +7.05 (+0.88%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$812.52 -0.50 (-0.06%)

As of 07/13/2026 07:56 PM Eastern

Compare

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

Should you buy McKesson stock or one of its competitors? MarketBeat compares McKesson with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with McKesson include HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), Neogen (NEOG), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.24	$4.76B	$38.47	21.13
HealthEquity	$1.31B	6.09	$215.20M	$2.67	35.83

McKesson presently has a consensus price target of $960.53, suggesting a potential upside of 18.14%. HealthEquity has a consensus price target of $110.57, suggesting a potential upside of 15.59%. Given McKesson's stronger consensus rating and higher probable upside, equities analysts clearly believe McKesson is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77

85.1% of McKesson shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

McKesson has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
HealthEquity	17.25%	14.75%	9.22%

In the previous week, McKesson had 19 more articles in the media than HealthEquity. MarketBeat recorded 26 mentions for McKesson and 7 mentions for HealthEquity. McKesson's average media sentiment score of 1.19 beat HealthEquity's score of 0.82 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	20 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

McKesson beats HealthEquity on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
Henry Schein	2.95%	15.44%	5.53%

In the previous week, McKesson had 18 more articles in the media than Henry Schein. MarketBeat recorded 26 mentions for McKesson and 8 mentions for Henry Schein. McKesson's average media sentiment score of 1.19 beat Henry Schein's score of 1.17 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	20 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

85.1% of McKesson shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 0.9% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

McKesson presently has a consensus price target of $960.53, indicating a potential upside of 18.14%. Henry Schein has a consensus price target of $87.64, indicating a potential upside of 2.16%. Given McKesson's stronger consensus rating and higher probable upside, equities research analysts clearly believe McKesson is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.40

McKesson has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.24	$4.76B	$38.47	21.13
Henry Schein	$13.18B	0.74	$398M	$3.31	25.92

Summary

McKesson beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

McKesson (NYSE:MCK) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

McKesson presently has a consensus price target of $960.53, suggesting a potential upside of 18.14%. Merit Medical Systems has a consensus price target of $92.80, suggesting a potential upside of 26.67%. Given Merit Medical Systems' higher possible upside, analysts plainly believe Merit Medical Systems is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

McKesson has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.24	$4.76B	$38.47	21.13
Merit Medical Systems	$1.52B	2.88	$128.49M	$2.31	31.71

Merit Medical Systems has a net margin of 9.03% compared to McKesson's net margin of 1.18%. Merit Medical Systems' return on equity of 13.54% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
Merit Medical Systems	9.03%	13.54%	7.94%

In the previous week, McKesson had 24 more articles in the media than Merit Medical Systems. MarketBeat recorded 26 mentions for McKesson and 2 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.25 beat McKesson's score of 1.19 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	20 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

85.1% of McKesson shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Merit Medical Systems beats McKesson on 10 of the 16 factors compared between the two stocks.

How does McKesson compare to Neogen?

Neogen (NASDAQ:NEOG) and McKesson (NYSE:MCK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

96.7% of Neogen shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.6% of Neogen shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$894.66M	2.35	-$1.09B	-$2.80	N/A
McKesson	$403.43B	0.24	$4.76B	$38.47	21.13

Neogen has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market. Comparatively, McKesson has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

McKesson has a net margin of 1.18% compared to Neogen's net margin of -69.93%. Neogen's return on equity of 2.35% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-69.93%	2.35%	1.46%
McKesson	1.18%	-345.35%	5.85%

In the previous week, McKesson had 24 more articles in the media than Neogen. MarketBeat recorded 26 mentions for McKesson and 2 mentions for Neogen. McKesson's average media sentiment score of 1.19 beat Neogen's score of 0.93 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	20 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Neogen presently has a consensus target price of $10.67, suggesting a potential upside of 10.54%. McKesson has a consensus target price of $960.53, suggesting a potential upside of 18.14%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than Neogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

Summary

McKesson beats Neogen on 11 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and McKesson (NYSE:MCK) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

In the previous week, McKesson had 9 more articles in the media than AMN Healthcare Services. MarketBeat recorded 26 mentions for McKesson and 17 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.19 beat AMN Healthcare Services' score of 0.38 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
McKesson	20 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

AMN Healthcare Services has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

McKesson has a net margin of 1.18% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
McKesson	1.18%	-345.35%	5.85%

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.48	-$95.70M	-$0.87	N/A
McKesson	$403.43B	0.24	$4.76B	$38.47	21.13

AMN Healthcare Services currently has a consensus price target of $27.00, suggesting a potential downside of 20.52%. McKesson has a consensus price target of $960.53, suggesting a potential upside of 18.14%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

Summary

McKesson beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$94.36B	$16.66B	$7.05B	$23.46B
Dividend Yield	0.41%	1.32%	2.68%	4.02%
P/E Ratio	21.13	19.37	27.11	31.08
Price / Sales	0.24	2.41	587.92	19.77
Price / Cash	17.68	14.34	29.22	18.64
Price / Book	-56.03	3.39	10.75	4.77
Net Income	$4.76B	$534.24M	$3.58B	$1.06B
7 Day Performance	0.93%	1.91%	-2.06%	-0.23%
1 Month Performance	3.72%	4.05%	3.32%	-0.11%
1 Year Performance	13.48%	4.24%	26.35%	16.46%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.9643 of 5 stars	$813.01 +0.9%	$960.53 +18.1%	+14.8%	$94.36B	$403.43B	21.13	43,000	Positive News
HQY HealthEquity	3.8067 of 5 stars	$96.57 +1.3%	$110.57 +14.5%	+1.2%	$8.07B	$1.34B	36.17	2,814	Positive News
HSIC Henry Schein	3.7599 of 5 stars	$86.62 +0.2%	$87.85 +1.4%	+16.8%	$9.87B	$13.18B	26.17	25,000	Analyst Downgrade
MMSI Merit Medical Systems	4.1742 of 5 stars	$71.45 +0.5%	$92.80 +29.9%	-21.6%	$4.26B	$1.52B	30.93	7,500	Positive News Analyst Forecast
NEOG Neogen	1.4793 of 5 stars	$9.51 +1.8%	$10.67 +12.2%	+79.0%	$2.07B	$870.56M	N/A	2,110

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to Neogen?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Which has stronger earnings & valuation, MCK or HQY?

Do analysts rate MCK or HQY?

Do institutionals and insiders hold more shares of MCK or HQY?

Which has more volatility and risk, MCK or HQY?

Is MCK or HQY more profitable?

Does the media favor MCK or HQY?

Summary

How does McKesson compare to Henry Schein?

Is MCK or HSIC more profitable?

Does the media refer more to MCK or HSIC?

Do institutionals & insiders believe in MCK or HSIC?

Do analysts rate MCK or HSIC?

Which has more volatility & risk, MCK or HSIC?

Which has better earnings & valuation, MCK or HSIC?

Summary

How does McKesson compare to Merit Medical Systems?

Do analysts rate MCK or MMSI?

Which has more risk & volatility, MCK or MMSI?

Which has stronger valuation & earnings, MCK or MMSI?

Is MCK or MMSI more profitable?

Does the media refer more to MCK or MMSI?

Do institutionals & insiders hold more shares of MCK or MMSI?

Summary

How does McKesson compare to Neogen?

Do institutionals and insiders hold more shares of NEOG or MCK?

Which has higher earnings & valuation, NEOG or MCK?

Which has more volatility and risk, NEOG or MCK?

Is NEOG or MCK more profitable?

Does the media prefer NEOG or MCK?

Do analysts prefer NEOG or MCK?

Summary

How does McKesson compare to AMN Healthcare Services?

Does the media prefer AMN or MCK?

Do institutionals & insiders hold more shares of AMN or MCK?

Which has more volatility & risk, AMN or MCK?

Is AMN or MCK more profitable?

Which has better earnings & valuation, AMN or MCK?

Do analysts rate AMN or MCK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools